Geron (GERN) News Today $4.02 +0.03 (+0.75%) (As of 11/21/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Geron: A Strong Launch And Financial Deals Make It AttractiveNovember 21 at 3:15 PM | seekingalpha.comFirst Turn Management LLC Purchases Shares of 3,124,967 Geron Co. (NASDAQ:GERN)First Turn Management LLC purchased a new stake in Geron Co. (NASDAQ:GERN - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 3,124,967 shares of the biopharmaceutical compNovember 19 at 6:08 AM | marketbeat.comRA Capital Management's Strategic Acquisition of Geron Corp SharesNovember 15, 2024 | gurufocus.comDeep Track Capital's Strategic Reduction in Geron Corp HoldingsNovember 14, 2024 | gurufocus.comGeron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and DevelopmentNovember 11, 2024 | businesswire.comGeron to Participate in the Stifel 2024 Healthcare ConferenceNovember 11, 2024 | businesswire.comTD Cowen Reaffirms Their Buy Rating on Geron (GERN)November 11, 2024 | markets.businessinsider.comGeron: Strong Sales Momentum and Strategic Financial Decisions Support ‘Buy’ RatingNovember 11, 2024 | markets.businessinsider.comWhat is B. Riley's Estimate for Geron FY2026 Earnings?Geron Co. (NASDAQ:GERN - Free Report) - B. Riley boosted their FY2026 earnings per share (EPS) estimates for Geron in a report released on Thursday, November 7th. B. Riley analyst K. Patel now forecasts that the biopharmaceutical company will earn $0.19 per share for the year, up from their previNovember 11, 2024 | marketbeat.comStifel Nicolaus Remains a Buy on Geron (GERN)November 11, 2024 | markets.businessinsider.comLeerink Partnrs Forecasts Geron's Q2 Earnings (NASDAQ:GERN)Geron Co. (NASDAQ:GERN - Free Report) - Analysts at Leerink Partnrs dropped their Q2 2025 EPS estimates for shares of Geron in a research report issued on Thursday, November 7th. Leerink Partnrs analyst F. Khurshid now forecasts that the biopharmaceutical company will earn $0.01 per share for theNovember 11, 2024 | marketbeat.comQ1 Earnings Estimate for Geron Issued By HC WainwrightGeron Co. (NASDAQ:GERN - Free Report) - Stock analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for Geron in a research note issued on Thursday, November 7th. HC Wainwright analyst E. Bodnar expects that the biopharmaceutical company will post earnings of ($0.03) per shaNovember 11, 2024 | marketbeat.comAnalysts Are Upgrading Geron Corporation (NASDAQ:GERN) After Its Latest ResultsNovember 10, 2024 | finance.yahoo.comGeron Corporation (NASDAQ:GERN) Q3 2024 Earnings Call TranscriptNovember 10, 2024 | msn.comGeron Corporation Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNovember 8, 2024 | uk.finance.yahoo.comGeron Secures $250M Funding and Strong Q3 SalesNovember 8, 2024 | finance.yahoo.comGeron Corp (GERN) Q3 2024 Earnings Call Highlights: Strong Rytelo Launch and Strategic ...November 8, 2024 | finance.yahoo.comBarclays Sticks to Its Buy Rating for Geron (GERN)November 8, 2024 | markets.businessinsider.comScotiabank Keeps Their Buy Rating on Geron (GERN)November 8, 2024 | markets.businessinsider.comGeron (GERN) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | msn.comGeron (NASDAQ:GERN) Issues Quarterly Earnings Results, Beats Estimates By $0.05 EPSGeron (NASDAQ:GERN - Get Free Report) released its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.05. The company had revenue of $28.27 million for the quarter, compared to analyst estimates of $18.97 million. Geron had a negative return on equity of 73.79% and a negative net margin of 15,990.68%. Geron's quarterly revenue was up 17138.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.08) EPS.November 8, 2024 | marketbeat.comGeron (NASDAQ:GERN) Sees Strong Trading Volume - Time to Buy?Geron (NASDAQ:GERN) Sees Large Volume Increase - Here's What HappenedNovember 7, 2024 | marketbeat.comGeron: A Post Earnings And Funding Announcement AssessmentNovember 7, 2024 | seekingalpha.comGeron Corporation (GERN) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comWhat is HC Wainwright's Estimate for Geron Q4 Earnings?Geron Co. (NASDAQ:GERN - Free Report) - Investment analysts at HC Wainwright issued their Q4 2024 earnings per share estimates for Geron in a research note issued to investors on Tuesday, November 5th. HC Wainwright analyst E. Bodnar anticipates that the biopharmaceutical company will earn ($0.08November 7, 2024 | marketbeat.comGeron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon AdvisorsNovember 7, 2024 | businesswire.comGeron started at buy by H.C. Wainwright ahead of Q3 earningsNovember 7, 2024 | msn.comGeron Co. (NASDAQ:GERN) Given Average Recommendation of "Buy" by BrokeragesGeron Co. (NASDAQ:GERN - Get Free Report) has been given an average rating of "Buy" by the eleven ratings firms that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy ratingNovember 7, 2024 | marketbeat.comH.C. Wainwright: "Rytelo startet stark" - Kaufempfehlung für Geron-AktienNovember 6, 2024 | de.investing.comGeron initiated with a Buy at H.C. WainwrightNovember 6, 2024 | markets.businessinsider.comHC Wainwright & Co. Initiates Coverage of Geron (GERN) with Buy RecommendationNovember 6, 2024 | msn.comGeron Q3 2024 Earnings PreviewNovember 6, 2024 | msn.comHC Wainwright Estimates Geron's Q3 Earnings (NASDAQ:GERN)Geron Co. (NASDAQ:GERN - Free Report) - Investment analysts at HC Wainwright issued their Q3 2024 EPS estimates for shares of Geron in a research report issued to clients and investors on Tuesday, November 5th. HC Wainwright analyst E. Bodnar anticipates that the biopharmaceutical company will poNovember 6, 2024 | marketbeat.comHC Wainwright Begins Coverage on Geron (NASDAQ:GERN)HC Wainwright assumed coverage on shares of Geron in a research report on Tuesday. They set a "buy" rating and a $8.00 target price on the stock.November 5, 2024 | marketbeat.comabrdn plc Invests $6.75 Million in Geron Co. (NASDAQ:GERN)abrdn plc acquired a new position in Geron Co. (NASDAQ:GERN - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 1,487,258 shares of the biopharmaceutical company's stock, valued at approximately $6,752,000November 3, 2024 | marketbeat.comGeron (GERN) to Release Quarterly Earnings on ThursdayGeron (NASDAQ:GERN) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=635885)October 31, 2024 | marketbeat.comGeron: Strategic Financial Moves and Long-Term Stability with Royalty FinancingOctober 26, 2024 | markets.businessinsider.comB.Riley setzt Kursziel für Geron-Aktie fest und hält an Kaufempfehlung aufgrund starker Rytelo-Verkäufe festOctober 23, 2024 | de.investing.comScotiabank Initiates Coverage of Geron (GERN) with Sector Outperform RecommendationOctober 17, 2024 | msn.comIs Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds?October 17, 2024 | msn.comGeron (NASDAQ:GERN) Receives New Coverage from Analysts at ScotiabankScotiabank began coverage on Geron in a research report on Wednesday. They issued a "sector outperform" rating for the company.October 16, 2024 | marketbeat.comGeron to Announce Third Quarter 2024 Financial Results on November 7, 2024October 15, 2024 | businesswire.comGeron (NASDAQ:GERN) Shares Down 3% - Should You Sell?Geron (NASDAQ:GERN) Trading Down 3% - Time to Sell?October 14, 2024 | marketbeat.comGeron Co. (NASDAQ:GERN) Receives Average Rating of "Buy" from AnalystsGeron Co. (NASDAQ:GERN - Get Free Report) has been given an average recommendation of "Buy" by the nine ratings firms that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has given aOctober 13, 2024 | marketbeat.comIs Geron Corporation (GERN) the Best Growth Stock Under $10 to Buy?October 12, 2024 | msn.comBuy Rating on Geron’s Stock Backed by Rytelo’s Strong Sales Performance and Market PotentialOctober 11, 2024 | markets.businessinsider.comIs Geron Corporation (GERN) the Best Stock Under $10 With High Potential?October 10, 2024 | msn.comGeron Corp (GERN) Q2 2024 Earnings Call Highlights: Strong Financial Position Amid Early Rytelo ...October 9, 2024 | finance.yahoo.comWall Street Analysts Rate Geron Corporation (GERN) as a Buy Amid Strong Growth ProspectsOctober 9, 2024 | msn.comThe Manufacturers Life Insurance Company Acquires 553,081 Shares of Geron Co. (NASDAQ:GERN)The Manufacturers Life Insurance Company raised its position in shares of Geron Co. (NASDAQ:GERN - Free Report) by 152.4% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 915,949 shares of the biopharmaceutical comOctober 8, 2024 | marketbeat.com Get Geron News Delivered to You Automatically Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter. Email Address What Comes Next Could Be a Once-in-a-Lifetime Opportunity (Ad)A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come. Click here now to watch the full briefing and discover the steps to take today. GERN Media Mentions By Week GERN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GERN News Sentiment▼0.610.48▲Average Medical News Sentiment GERN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GERN Articles This Week▼35▲GERN Articles Average Week Get Geron News Delivered to You Automatically Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ORGO News Today FHTX News Today RGEN News Today MDGL News Today HALO News Today IONS News Today ALKS News Today FOLD News Today LGND News Today MNKD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GERN) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Geron Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Geron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free gern Stock Alerts